“Molecular Docking Study Of Thymoquinone With Target Proteins Involved In Choleserol Biosynthesis”, Journal of Pharmaceutical Negative Results, pp. 2177–2182, Nov. 2022, doi: 10.47750/pnr.2022.13.S04.271.